Format

Send to

Choose Destination
Pharmacol Res. 2018 May;131:112-119. doi: 10.1016/j.phrs.2018.03.009. Epub 2018 Mar 14.

Curcumin in heart failure: A choice for complementary therapy?

Author information

1
Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
2
Cardiology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
3
Life Sciences Research Division, Anti-Doping Laboratory Qatar, Sports City Road, Doha, Qatar.
4
Weill Cornell Medicine Qatar, Doha, Qatar.
5
Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: sahebkara@mums.ac.ir.

Abstract

Heart failure is a major public health concern and one of the most common reasons for a cardiac hospital admission. Heart failure may be classified as having a reduced or preserved ejection fraction and its severity is based on the symptom score. Given the aging population, it is predicted that admissions with heart failure will increase. Whilst pharmacological therapy has improved the associated morbidity and mortality, there is a need for additional therapies to improve the clinical outcome as the death rate remains high. Curcumin is a natural product derived from turmeric that appears to have cardiovascular benefit through a number of mechanisms. In this review, we have assessed the mechanisms by which curcumin may exert its effects in different models of heart failure and show that it has promise as a complementary treatment in heart failure.

KEYWORDS:

Cardiovascular disorders; Complementary medicine; Curcumin; Heart failure

PMID:
29550354
DOI:
10.1016/j.phrs.2018.03.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center